ketamine has been researched along with Brain Hemorrhage in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Welling, L | 1 |
Welling, MS | 1 |
Teixeira, MJ | 1 |
Figueiredo, EG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
S-ketamine for Cortical Spreading Depolarisation in Patients With Severe Acute Brain Injury[NCT05095857] | Phase 4 | 400 participants (Anticipated) | Interventional | 2023-09-15 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 other study available for ketamine and Brain Hemorrhage
Article | Year |
---|---|
Cortical spread depolarization and ketamine: a revival of an old drug or a new era of neuroprotective drugs?
Topics: Brain Ischemia; Cerebrovascular Circulation; Cortical Spreading Depression; Humans; Intracranial Hem | 2015 |